Veradigm (NASDAQ:MDRX) Sees Unusually-High Trading Volume – Time to Buy?

Veradigm Inc. (NASDAQ:MDRX) shares saw unusually-high trading volume on Wednesday . Approximately 424,727 shares traded hands during trading, an increase of 172% from the previous session’s volume of 156,230 shares.The stock last traded at $4.90 and had previously closed at $4.95.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Veradigm Price Performance

The stock has a market cap of $599.27 million, a PE ratio of 23.25 and a beta of 0.55. The stock’s fifty day moving average is $4.73 and its 200-day moving average is $4.66.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.